XML 84 R95.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Numerator:                      
Net income attributable to Biogen Idec Inc $ 1,439.7 $ 1,545.9 $ 1,494.1 $ 1,408.8 $ 946.8 $ 1,444.4 $ 866.6 $ 1,172.9 $ 5,888.5 $ 4,430.7 $ 2,539.1
Denominator:                      
Weighted average number of common shares outstanding 177.8 184.0 190.3 196.6 199.8 201.4 207.1 211.4 187.1 204.9 212.6
Effect of dilutive securities:                      
Dilutive potential common shares                 0.3 0.4 0.4
Shares used in calculating diluted earnings per share 178.2 184.2 190.4 197.0 200.3 201.9 207.3 211.7 187.4 205.3 213.0
Earnings per share (Textual)                      
Repurchase of common stock                 23.6 14.8 3.7
Stock options and employee stock purchase plan                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.0 0.0 0.1
Time-vested restricted stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.2 0.3 0.2
Market stock units                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.1 0.1 0.1
Performance stock units settled in stock                      
Effect of dilutive securities:                      
Stock options and employee stock purchase plan                 0.0 0.0 0.0